CWC
CO

Carolinas Wealth Consulting’s Global Cord Blood Corporation CO Stock Holding History

Carolinas Wealth Consulting’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,600
Closed -$9K – 1021
2021
Q2 		$9K Buy
+1,600
New +$8.37K ﹤0.01% 624

Other funds holding CO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Carolinas Wealth Consulting's CO Position: Q3 2021 in Review

Carolinas Wealth Consulting sold out of Global Cord Blood Corporation (CO) in Q3 2021, closing a stake of 1,600 shares — an estimated $9K sold.

Carolinas Wealth Consulting first reported a position in CO in Q2 2021 and held it in 1 quarter. The position peaked at $9K in Q2 2021. 28 funds tracked by Wall St. Rank hold CO as of Q3 2021.

  • Carolinas Wealth Consulting reported no remaining Global Cord Blood Corporation position as of Q3 2021 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 1,600 Global Cord Blood Corporation shares in Q3 2021, an estimated $9K.
  • Carolinas Wealth Consulting first reported a position in Global Cord Blood Corporation in Q2 2021 and held it in 1 quarter.
  • Carolinas Wealth Consulting's Global Cord Blood Corporation position peaked at $9K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2021.

Based on Carolinas Wealth Consulting's 13F filing for Q3 2021, filed 15 Nov 2021.